Evolution of Early SARS-CoV-2 and Cross-Coronavirus Immunity
The novel coronavirus, SARS-coronavirus (CoV)-2 (SARS-CoV-2), has caused over 17 million infections in just a few months, with disease manifestations ranging from largely asymptomatic infection to critically severe disease. The remarkable spread and unpredictable disease outcomes continue to challen...
| Main Authors: | , , , , , , , , , |
|---|---|
| Other Authors: | |
| Format: | Article |
| Published: |
American Society for Microbiology
2020
|
| Online Access: | https://hdl.handle.net/1721.1/127199 |